The Philippines’ pharmaceutical market is projected to grow from P525 billion in 2025 to P759 billion by 2030, with a compound annual growth rate of 7.6 percent, according to BMI Research.
The growth is expected to be driven by investments in local drug manufacturing and government initiatives, including a “green lane” to streamline regulatory processes for new facilities.
Despite these efforts, the country faces a $2.3-billion pharmaceutical trade deficit and remains heavily dependent on imported medicines.
Challenges to the sector’s expansion include limited financial resources, skilled human capital, and lengthy FDA approval processes that can delay product launches for years.
BMI noted that while policy measures support growth, structural constraints may continue to limit advanced pharmaceutical manufacturing and research in the Philippines.
Source: PhilNews24 | March 23, 2026
PHILIPPINE PHARMA MARKET GROWTH COULD TOP P759 BILLION BY 2030
Latest from Business
Shakey’s Pizza Asia Ventures Inc. is restructuring its store network by closing 15 to 20 underperforming
The World Bank has urged the Philippines to prioritize full implementation of the Extended Producer Responsibility
The government is seeking private sector support to develop three offshore wind terminals that could cost
Fast Retailing Co., Ltd., the parent company of UNIQLO, will donate JPY 30 million (approximately US$185,000)
The Philippines’ tuna catch rose by 14.6 percent to an estimated 230,347 metric tons in 2025,